Funder
Nanjing Medical Science and Technique Development Foundation
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. NCD-RisC NRFC (2021) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398(10304):957–80
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982–3021
3. Sasaki N, Ozono R, Higashi Y, Maeda R, Kihara Y (2020) Association of insulin resistance, plasma glucose level, and serum insulin level with hypertension in a population with different stages of impaired glucose metabolism. J Am Heart Assoc 9(7):e15546
4. Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR (2014) Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am 43(1):103–122
5. Wang Y, Ye C, Kong L, Zheng J, Xu M, Xu Y et al (2023) Independent associations of education, intelligence, and cognition with hypertension and the mediating effects of cardiometabolic risk factors: a mendelian randomization study. Hypertension 80(1):192–203